These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7784412)

  • 1. [Critical serum concentration of antibiotics. A therapeutic tool and means of comparative evaluation].
    Potel G; Caillon J; Xiong YQ; Bugnon D; Conte PL; Drugeon HB; Baron D
    Presse Med; 1995 Apr; 24(16):750-2. PubMed ID: 7784412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis.
    Juvin ME; Potel G; Caillon J; Xiong YQ; Bugnon D; Le Conte P; Baron DI; Drugeon HB
    Antimicrob Agents Chemother; 1994 Apr; 38(4):883-5. PubMed ID: 8031065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
    Mah FS; Romanowski EG; Kowalski RP; Yates KA; Gordon YJ
    Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa.
    Xiong YQ; Potel G; Caillon J; Stephant G; Jehl F; Bugnon D; Le Conte P; Baron D; Drugeon H
    Antimicrob Agents Chemother; 1995 Feb; 39(2):496-9. PubMed ID: 7726520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential distributions in tissues and efficacies of aztreonam and ceftazidime and in vivo bacterial morphological changes following treatment.
    Turcotte A; Simard M; Morin NJ; Beauchamp D; Bergeron MG
    Antimicrob Agents Chemother; 1997 Feb; 41(2):401-9. PubMed ID: 9021198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ciprofloxacin in experimental aortic valve endocarditis caused by a multiply beta-lactam-resistant variant of Pseudomonas aeruginosa stably derepressed for beta-lactamase production.
    Bayer AS; Lindsay P; Yih J; Hirano L; Lee D; Blomquist IK
    Antimicrob Agents Chemother; 1986 Oct; 30(4):528-31. PubMed ID: 3539007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of pharmacodynamics in determining the dosing interval in therapy for experimental pseudomonas endocarditis in the rat.
    Ingerman MJ; Pitsakis PG; Rosenberg AF; Levison ME
    J Infect Dis; 1986 Apr; 153(4):707-14. PubMed ID: 2936832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ceftazidime in the treatment of meningitis caused by multiresistant Serratia marcescens].
    Munemoto S; Nomura M; Ishiguro S; Kuroda E; Nakashima Y
    Jpn J Antibiot; 1992 Oct; 45(10):1275-81. PubMed ID: 1479679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antibacterial effects of simulated human serum profiles of once-daily versus thrice-daily dosing of amikacin in a Serratia marcescens endocarditis experimental model.
    Bugnon D; Potel G; Xiong YQ; Caillon J; Kergueris MF; Le Conte P; Baron D; Drugeon H
    Antimicrob Agents Chemother; 1996 May; 40(5):1164-9. PubMed ID: 8723459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal effect of pefloxacin and fosfomycin against Pseudomonas aeruginosa in a rabbit endocarditis model with pharmacokinetics of pefloxacin in humans simulated in vivo.
    Bugnon D; Potel G; Xiong YQ; Caillon J; Navas D; Gras C; Kergueris MF; Le Conte P; Jehl F; Baron D; Drugeon H
    Eur J Clin Microbiol Infect Dis; 1997 Aug; 16(8):575-80. PubMed ID: 9323468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serratia marcescens endocarditis in a horse.
    Ewart S; Brown C; Derksen F; Kufuor-Mensa E
    J Am Vet Med Assoc; 1992 Apr; 200(7):961-3. PubMed ID: 1577651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative therapeutic efficacy of clinafloxacin in a Pseudomonas aeruginosa mouse renal abscess model.
    Shapiro MA; Sesnie JC; Desaty TM; Griffin TJ; Heifetz CL
    J Antimicrob Chemother; 1998 Mar; 41(3):403-5. PubMed ID: 9578169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative activities of pefloxacin and ciprofloxacin in the treatment of chronic respiratory tract infections.
    Scaglione F; Scamazzo F; Arcidiacono MM; Cogo R; Monzani GP; Fraschini F
    J Chemother; 1995 Apr; 7(2):140-5. PubMed ID: 7666121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pefloxacin versus ceftazidime in therapy of soft tissue infections in compromised patients.
    Segev S; Rosen N; Pitlik SD; Block C; Rubinstein E
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():193-8. PubMed ID: 2258349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serratia marcescens keratitis after photorefractive keratectomy.
    Rahimi F; Hashemian MN; Khodabande A
    J Cataract Refract Surg; 2009 Sep; 35(9):1645-6. PubMed ID: 19683170
    [No Abstract]   [Full Text] [Related]  

  • 17. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
    J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current therapeutical management, new antibiotics and treatment of Pseudomonas aeruginosa in bacterial ENT-infections].
    Elies W
    Laryngorhinootologie; 2002 Jan; 81(1):40-5. PubMed ID: 11845401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
    Lu Q; Yang J; Liu Z; Gutierrez C; Aymard G; Rouby JJ;
    Am J Respir Crit Care Med; 2011 Jul; 184(1):106-15. PubMed ID: 21474643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Skin infection due to Serratia marcescens in an immunocompetent patient].
    Giráldez P; Mayo E; Pavón P; Losada A
    Actas Dermosifiliogr; 2011 Apr; 102(3):236-7. PubMed ID: 21345399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.